INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer.
- DOI
- 10.3389/fonc.2021.653370
- Published
- 2021
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2021.653370,
title = {INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer.},
author = {Veyssière H and Lusho S and Molnar I and Kossai M and Bernadach M and Abrial C and Bidet Y and Radosevic-Robin N and Durando X},
year = {2021},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2021.653370},
url = {https://doi.org/10.3389/fonc.2021.653370}
}RIS
TY - JOUR TI - INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer. AU - Veyssière H AU - Lusho S AU - Molnar I AU - Kossai M AU - Bernadach M AU - Abrial C AU - Bidet Y AU - Radosevic-Robin N AU - Durando X PY - 2021 JO - Frontiers in oncology DO - 10.3389/fonc.2021.653370 UR - https://doi.org/10.3389/fonc.2021.653370 ER -
APA
H, V., S, L., I, M., M, K., M, B., C, A., Y, B., N, R., & X, D. (2021). INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer.. Frontiers in oncology. https://doi.org/10.3389/fonc.2021.653370
Source records
- pubmed · retrieved 2026-09-25T23:00:18.009Z